Company Profile

Company Description

RELMADA THERAPEUTICS, INC. is a clinical-stage biotechnology company focused on developing novel therapies to address central nervous system disorders and other underserved conditions. The company specializes in innovative treatments for depression, chronic pain, and other mental health challenges. Its lead investigational drug, esmethadone, is being studied as a rapid-acting oral antidepressant with potential to transform treatment paradigms. The firm emphasizes patient-centric approaches while advancing its pipeline through rigorous clinical trials. With a commitment to addressing unmet medical needs, it leverages cutting-edge research to develop next-generation therapeutics that could improve quality of life for individuals suffering from debilitating conditions.